Amprius Technologies (NYSE:AMPX) Stock Price Down 5.1% - Should You Sell?

Key Points

• Shares fell 5.1% to about $17.74 on Tuesday with 7.87M shares traded (below the ~9.03M average); market cap is roughly $2.43B and the stock trades above its 50‑day ($13.01) and 200‑day ($11.62) moving averages.
• Analysts have a consensus rating of Moderate Buy (eight Buys, one Sell) with an average target of $19.75 and individual targets rising as high as $22.00.
• The company beat the quarter (EPS -$0.01 vs -$0.04 est.; revenue $25.23M vs $22.91M) but remains unprofitable with negative margins and FY2026 guidance of -$0.06, analysts forecast ~-0.45 EPS for the year, and insiders sold about 2.93M shares (~$37.8M) in the last 90 days (insiders still own 12.9%).

Amprius Technologies, Inc. (NYSE:AMPX - Get Free Report)'s stock price fell 5.1% on Tuesday . The company traded as low as $17.34 and last traded at $17.7360. 7,865,717 shares were traded during mid-day trading, a decline of 13% from the average session volume of 9,034,770 shares. The stock had previously closed at $18.68.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on AMPX shares. Weiss Ratings restated a "sell (e+)" rating on shares of Amprius Technologies in a report on Wednesday, January 21st. Oppenheimer reiterated an "outperform" rating and issued a $17.00 target price on shares of Amprius Technologies in a report on Tuesday, December 23rd. Needham & Company LLC reissued a "buy" rating and set a $20.00 price target on shares of Amprius Technologies in a research report on Tuesday, March 10th. Cantor Fitzgerald boosted their price target on shares of Amprius Technologies from $16.00 to $20.00 and gave the company an "overweight" rating in a report on Friday, March 6th. Finally, B. Riley Financial upped their price objective on shares of Amprius Technologies from $16.00 to $22.00 and gave the company a "buy" rating in a research report on Monday, March 9th. Eight analysts have rated the stock with a Buy rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $19.75.

Amprius Technologies Trading Down 5.1%

The stock's 50 day moving average is $13.01 and its two-hundred day moving average is $11.62. The stock has a market capitalization of $2.43 billion, a price-to-earnings ratio of -52.16 and a beta of 3.04.

Amprius Technologies (NYSE:AMPX - Get Free Report) last released its quarterly earnings results on Wednesday, March 4th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.03. The firm had revenue of $25.23 million for the quarter, compared to the consensus estimate of $22.91 million. Amprius Technologies had a negative return on equity of 24.29% and a negative net margin of 60.30%.Amprius Technologies has set its FY 2026 guidance at --0.060 EPS. On average, research analysts anticipate that Amprius Technologies, Inc. will post -0.45 earnings per share for the current year.

Insider Transactions at Amprius Technologies

In related news, CTO Constantin Ionel Stefan sold 492,827 shares of Amprius Technologies stock in a transaction that occurred on Thursday, January 22nd. The stock was sold at an average price of $12.04, for a total value of $5,933,637.08. Following the sale, the chief technology officer owned 748,696 shares of the company's stock, valued at approximately $9,014,299.84. This trade represents a 39.70% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Kang Sun sold 950,548 shares of the business's stock in a transaction that occurred on Friday, January 16th. The shares were sold at an average price of $11.07, for a total value of $10,522,566.36. Following the completion of the sale, the director owned 1,403,651 shares in the company, valued at $15,538,416.57. The trade was a 40.38% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 2,929,357 shares of company stock valued at $37,783,110 in the last ninety days. Corporate insiders own 12.90% of the company's stock.

Institutional Trading of Amprius Technologies

A number of institutional investors have recently made changes to their positions in AMPX. Alberta Investment Management Corp bought a new position in Amprius Technologies in the fourth quarter valued at $1,001,000. Vident Advisory LLC acquired a new stake in Amprius Technologies in the 4th quarter valued at $107,000. Summit Securities Group LLC bought a new stake in Amprius Technologies during the 4th quarter worth about $54,000. Numerai GP LLC lifted its position in Amprius Technologies by 29.1% during the 4th quarter. Numerai GP LLC now owns 96,209 shares of the company's stock worth $759,000 after buying an additional 21,698 shares in the last quarter. Finally, Osterweis Capital Management Inc. boosted its stake in shares of Amprius Technologies by 142.6% during the 4th quarter. Osterweis Capital Management Inc. now owns 454,830 shares of the company's stock worth $3,589,000 after buying an additional 267,385 shares during the last quarter. Institutional investors own 5.04% of the company's stock.

About Amprius Technologies

Amprius Technologies, Inc NYSE: AMPX is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company's batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius' product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.